LINC00665 can upregulate SND1 and RRAGD by sponging miR-1224-5p and miR-449b-5p, and promote the progression of prostate cancer [14] and high-grade serous ovarian cancer [19], respectively. Here, LINC00665 is linked to prostate carcinoma.